This inventor holds 48 USPTO granted patents and 15 published patent applications, primarily in Medical Device Innovation. Top assignees: Abbott Diabetes Care Inc., Other. Active years: 2011-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Carlsbad, CA (US) (2014 - 2015)
- Winona Lake, IN (US) (2013 - 2017)
- San Francisco, CA (US) (2011 - 2024)
- Portland, OR (US) (2015 - 2024)
Company Filing History:
46 out of 1,450 
2 out of 834,570 Years Active: 2011-2025
Areas of Expertise:
Title: R Curtis Jennewine: A Pioneer in Diabetes Management Innovations
Introduction
R Curtis Jennewine, based in Portland, Oregon, is a renowned inventor with an impressive portfolio of 45 patents. His work primarily focuses on innovations that improve diabetes management, particularly through integrated analyte monitoring systems and therapy management solutions.
Latest Patents
Jennewine's recent patents showcase groundbreaking advancements in diabetes care. One notable invention is the "Method and system for providing integrated analyte monitoring and infusion system therapy management." This patent details a system designed for diabetes management and insulin therapy, utilizing substantially real-time glucose monitoring technologies. Another significant patent, titled "Integrated analyte sensor and infusion device and methods therefor," presents a method for an integrated analyte monitoring system combined with an on-body patch pump featuring multiple cannulas and a sensor combination.
Career Highlights
Throughout his career, Jennewine has made substantial contributions to the field of medical technology, notably during his time with Abbott Diabetes Care Inc. His expertise in the development of innovative solutions has helped address critical challenges in diabetes management, impacting countless lives through improved healthcare technologies.
Collaborations
Jennewine has collaborated with notable professionals in the field, including Mark Kent Sloan and Timothy Christian Dunn. Their teamwork has been instrumental in driving advancements in diabetes care, further demonstrating the collaborative nature of technological innovation in the medical industry.
Conclusion
R Curtis Jennewine stands out as a pivotal figure in the realm of diabetes management innovations. His extensive patent portfolio and collaborations reflect a commitment to advancing healthcare through technology, making a lasting impact on the lives of individuals affected by diabetes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile